> Information Center > Technical FAQs > Genome Editing Technology Column > Types of ImmunotherapyCAR T-Cell Therapy
CAR T-cell is short for chimeric antigen receptor T-cell therapy. It’s also called adoptive cell transfer therapy, or ACT. It’s only used to treat two types of blood cancers:
Tisagenlecleucel (Kymriah) is used to treat children and adults up to age 25 with acute lymphoblastic leukemia (ALL) and adults with certain types of large B-cell lymphoma whose cancer didn’t respond to chemotherapy or who had the disease come back two or more times after treatment.
Axicabtagene ciloleucel (Yescarta) is approved to treat adults with some types of large B-cell lymphoma, such as non-Hodgkin's lymphoma, whose cancer didn’t respond to other treatments or who had the disease come back after those treatments.